Development of autoantibody signatures as biomarkers for early detection of colorectal carcinoma

Clinical Cancer Research

Volumn 17, Issue 17, 2011, Pages 5715-5724

  Chang, Wenjun ^a   Wu, Lingling ^a   Cao, Fuao ^a   Liu, Yan ^a   Ma, Liye ^a   Wang, Mei ^a   Zhao, Dongbao ^a   Li, Ping ^a   Zhang, Qi ^a   Tan, Xiaojie ^a   Yu, Yongwei ^a   Lou, Zheng ^a   Zhao, Jinfeng ^a   Zhang, Hongwei ^a   Fu, Chuangang ^a   Cao, Guangwen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CARCINOEMBRYONIC ANTIGEN; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BLOOD LEVEL; CLONE; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; FEMALE; FIVE PHAGE PEPTIDE CLASSIFIER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MESENCHYME CELL; PHAGE DISPLAY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD20; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BACTERIOPHAGE T7; CARCINOEMBRYONIC ANTIGEN; COLONIC POLYPS; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAINS; MALE; MIDDLE AGED; PEPTIDE LIBRARY; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 80052513331     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-11-0199     Document Type: Article

References (48)

1. Weitz J., Koch M., Debus J., Hohler T., Galle P.R., Buchler M.W. Colorectal cancer. Lancet 2005;365:153-165 (Pubitemid 40091806)
2. Allison J.E., Sakoda L.C., Levin T.R., Tucker J.P., Tekawa I.S., Cuff T., et al. Screening for colorectal neoplasms with new fecal occult blood tests: Update on performance characteristics. J Natl Cancer Inst 2007;99:1462-1470
3. Srivastava S., Verma M., Henson D.E. Biomarkers for early detection of colon cancer. Clin Cancer Res 2001;7:1118-1126 (Pubitemid 32708660)
4. Leman E.S., Schoen R.E., Magheli A., Sokoll L.J., Chan D.W., Getzenberg R.H. Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer. Clin Cancer Res 2008;14:1349-1354 (Pubitemid 351413914)
5. Kim H.J., Yu M.H., Kim H., Byun J., Lee C. Noninvasive molecular biomarkers for the detection of colorectal cancer. BMB Rep 2008;41:685-692
6. Nishimori I., Miyaji E., Morimoto K., Nagao K., Kamada M., Onishi S. Serum antibodies to carbonic anhydrase IV in patients with autoimmune pancreatitis. Gut 2005;54:274-281 (Pubitemid 40139246)
7. Caron M., Choquet-Kastylevsky G., Joubert-Caron R. Cancer immunomics using autoantibody signatures for biomarker discovery. Mol Cell Proteomics 2007;6:1115-1122 (Pubitemid 47099223)
8. Desmetz C., Cortijo C., Mangé A., Solassol J. Humoral response to cancer as a tool for biomarker discovery. J Proteomics 2009;72:982-988
9. Zhang J.Y., Megliorino R., Peng X.X., Tan E.M., Chen Y., Chan E.K. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma. J Hepatol 2007;46:107-114 (Pubitemid 44827418)
10. Lu H., Goodell V., Disis M.L. Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer. J Proteome Res 2008;7:1388-1394
11. Farlow E.C., Patel K., Basu S., Lee B.S., Kim A.W., Coon J.S., et al. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer. Clin Cancer Res 2010;16:3452-3462
12. Desmetz C., Bascoul-Mollevi C., Rochaix P., Lamy P.J., Kramar A., Rouanet P., et al. Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women. Clin Cancer Res 2009;15:4733-4741
13. Chen Y.T., Güre A.O., Tsang S., Stockert E., Jager E., Knuth A., et al. Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc Natl Acad Sci U S A 1998;95:6919-6923 (Pubitemid 28278082)
14. Ran Y., Hu H., Zhou Z., Yu L., Sun L., Pan J., et al. Profiling tumor-associated autoantibodies for the detection of colon cancer. Clin Cancer Res 2008;14:2696-2700
15. Wang X., Yu J., Sreekumar A., Varambally S., Shen R., Giacherio D., et al. Autoantibody signatures in prostate cancer. N Engl J Med 2005;353:1224-1235 (Pubitemid 41345944)
16. Chatterjee M., Mohapatra S., Ionan A., Bawa G., Ali-Fehmi R., Wang X., et al. Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res 2006;66:1181-1190 (Pubitemid 43165989)
17. Kijanka G., Murphy D. Protein arrays as tools for serum autoantibody marker discovery in cancer. J Proteomics 2009;72:936-944
18. Babel I., Barderas R., Díaz-Uriarte R., Martinez-Torrecuadrada J.L., Sanchez-Carbayo M., Casal J.I. Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays. Mol Cell Proteomics 2009;8:2382-2395
19. Gnjatic S., Ritter E., Büchler M.W., Giese N.A., Brors B., Frei C., et al. Seromic profiling of ovarian and pancreatic cancer. Proc Natl Acad Sci U S A 2010;107:5088-5093
20. Qiu J., Choi G., Li L., Wang H., Pitteri S.J., Pereira-Faca S.R., et al. Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera. J Clin Oncol 2008;26:5060-5066
21. Kijanka G., Hector S., Kay E.W., Murray F., Cummins R., Murphy D., et al. Human IgG antibody profiles differentiate between symptomatic patients with and without colorectal cancer. Gut 2010;59:69-78.
22. Chan C.C., Fan C.W., Kuo Y.B., Chen Y.H., Chang P.Y., Chen K.T., et al. Multiple serological biomarkers for colorectal cancer detection. Int J Cancer 2010;126:1683-1690
23. Zhang J.Y., Casiano C.A., Peng X.X., Koziol J.A., Chan E.K., Tan E.M. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. Cancer Epidemiol Biomarkers Prev 2003;12:136-143 (Pubitemid 36194003)
24. Wu L., Chang W., Zhao J., Yu Y., Tan X., Su T., et al. Development of autoantibody signatures as novel diagnostic biomarkers of non-small cell lung cancer. Clin Cancer Res 2010;16:3760-3768
25. Fan Y., Murphy T.B., Watson R.W. digeR: A graphical user interface R package for analyzing 2D-DIGE data. Bioinformatics 2009;25:3033-3034
26. Bild A.H., Yao G., Chang J.T., Wang Q., Potti A., Chasse D., et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006;439:353-357 (Pubitemid 43128862)
27. Potti A., Dressman H.K., Bild A., Riedel R.F., Chan G., Sayer R., et al. Genomic signatures to guide the use of chemotherapeutics. Nat Med 2006;12:1294-1300 (Pubitemid 44706932)
28. Fraser C.G., Matthew C.M., Mowat N.A., Wilson J.A., Carey F.A., Steele R.J. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: An observational study. Lancet Oncol 2006;7:127-131 (Pubitemid 43159498)
29. Ng E.K., Chong W.W., Jin H., Lam E.K., Shin V.Y., Yu J., et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: A potential marker for colorectal cancer screening. Gut 2010;58:1375-1381
30. Bujanda L., Cosme A., Gil I., Arenas-Mirave J.I. Malignant colorectal polyps. World J Gastroenterol 2010;16:3103-3111
31. Boparai K.S., Mathus-Vliegen E.M., Koornstra J.J., Nagengast F.M., Van Leerdam M., Van Noesel C.J., et al. Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: A multicentre cohort study. Gut 2010;59:1094-1100
32. Oono Y., Fu K., Nakamura H., Iriguchi Y., Yamamura A., Tomino Y., et al. Progression of a sessile serrated adenoma to an early invasive cancer within 8 months. Dig Dis Sci 2009;54:906-909
33. Meyerhof W., Batram C., Kuhn C., Brockhoff A., Chudoba E., Bufe B., et al. The molecular receptive ranges of human TAS2R bitter taste receptors. Chem Senses 2010;35:157-170
34. Twomey J.J., Rossen R.D., Lewis V.M., Laughter A.H., Douglass C.C. Rheumatoid factor and tumor-host interaction. Proc Natl Acad Sci U S A 1976;73:2106-2108
35. Jónsson T., Thorsteinsson J., Valdimarsson H. Rheumatoid factor isotypes and cancer prognosis. Cancer 1992;69:2160-2165
36. Chen Z., Gu J. Immunoglobulin G expression in carcinomas and cancer cell lines. FASEB J 2007;21:2931-2938 (Pubitemid 47372759)
37. Qiu X., Zhu X., Zhang L., Mao Y., Zhang J., Hao P., et al. Human epithelial cancers secrete immunoglobulin g with unidentified specificity to promote growth and survival of tumor cells. Cancer Res 2003;63:6488-6495 (Pubitemid 37255201)
38. Babbage G., Ottensmeier C.H., Blaydes J., Stevenson F.K., Sahota S.S. Immunoglobulin heavy chain locus events and expression of activation- induced cytidine deaminase in epithelial breast cancer cell lines. Cancer Res 2006;66:3996-4000.
39. Zheng J., Huang J., Mao Y., Liu S., Sun X., Zhu X., et al. Immunoglobulin gene transcripts have distinct VHDJH recombination characteristics in human epithelial cancer cells. J Biol Chem 2009;284:13610-13619
40. Zheng H., Li M., Ren W., Zeng L., Liu H.D., Hu D., et al. Expression and secretion of immunoglobulin alpha heavy chain with diverse VDJ recombinations by human epithelial cancer cells. Mol Immunol 2007;44:2221-2227 (Pubitemid 46097112)
41. Zheng H., Li M., Liu H., Ren W., Hu D.S., Shi Y., et al. Immunoglobulin alpha heavy chain derived from human epithelial cancer cells promotes the access of S phase and growth of cancer cells. Cell Biol Int 2007;31:82-87 (Pubitemid 46138048)
42. Chen Z., Huang X., Ye J., Pan P., Cao Q., Yang B., et al. Immunoglobulin G is present in a wide variety of soft tissue tumors and correlates well with proliferation markers and tumor grades. Cancer 2010;116:1953-1963
43. Asano T., Tada M., Cheng S., Takemoto N., Kuramae T., Abe M., et al. Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma. J Surg Res 2008;146:32-42. (Pubitemid 351442927)
44. Waas E.T., Lomme R.M., DeGroot J., Wobbes T., Hendriks T. Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer. Br J Cancer 2002;86:1876-1883
45. Baker E.A., Bergin F.G., Leaper D.J. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging. Br J Surg 2000;87:1215-1221
46. Ryan M.H., Petrone D., Nemeth J.F., Barnathan E., Bjorck L., Jordan R.E. Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluid. Mol Immunol 2008;45:1837-1846
47. Brezski R.J., Vafa O., Petrone D., Tam S.H., Powers G., Ryan M.H., et al. Tumor-associated and microbial proteases compromise host IgG effector functions by a single cleavage proximal to the hinge. Proc Natl Acad Sci U S A 2009;106:17864-17869
48. De Visser K.E., Korets L.V., Coussens L.M. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 2005;7:411-423 (Pubitemid 40719125)